Devices › Apparatus, suction, ward use, portable, ac-powered
Device brand name · Apparatus suction ward use portable ac-powered
Neptune 2 Rover Ultra 120v: medical device reports filed with FDA
243 reports name it, 2010–2020. Manufacturer given most often on reports: Stryker Instruments-Kalamazoo. Product code JCX.
- 243
- device reports naming the brand
- 0% of all MAUDE reports · about 15 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 95.1%
- classified as malfunction
- 82.4% across the product code
- 1.2%
- classified as death, as reported
- 3 reports · not verified by FDA
FDA's MAUDE database holds 243 reports that name the brand "Neptune 2 Rover Ultra 120v" (apparatus suction ward use portable ac-powered), received between May 2010 and October 2020; the manufacturer given most often on reports is Stryker Instruments-Kalamazoo. Spellings of one product vary from report to report.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (95.1%), injury (3.7%) and death (1.2%); across all apparatus, suction, ward use, portable, ac-powered reports (product code JCX) death is recorded in 2.5% and malfunction in 82.4%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are smoking (22.6%), electrical /electronic property problem (11.9%) and sparking (10.3%). The patient problems coded most often are no patient involvement, pain and shock. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
No report naming Neptune 2 Rover Ultra 120v was received in the five years to August 2026; the latest was received in October 2020.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 2,154 reports carrying product code JCX. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Smoking | 55 | 22.6% | 7.3% |
| Electrical /electronic property probleman electrical or electronic problem | 29 | 11.9% | 2.9% |
| Sparking | 25 | 10.3% | 2% |
| Suction problem | 24 | 9.9% | 11.2% |
| Filtration problem | 13 | 5.3% | 2.8% |
| Fluid/blood leak | 9 | 3.7% | 3.2% |
| Device operates differently than expectedthe device behaved unexpectedly | 8 | 3.3% | 2.4% |
| Device displays incorrect message | 5 | 2.1% | 0.1% |
| Device inoperablethe device could not be used | 5 | 2.1% | 0.2% |
| Inappropriate/inadequate shock/stimulation | 5 | 2.1% | 0.2% |
| Breakthe device broke | 4 | 1.6% | 1.4% |
| Cut in material | 4 | 1.6% | 0.2% |
| Material integrity problema problem with the device material | 4 | 1.6% | 0.3% |
| Fire | 3 | 1.2% | 0.4% |
| Loss of powerthe device lost power | 3 | 1.2% | 0.2% |
| Mechanical problema mechanical problem | 3 | 1.2% | 0.1% |
| Overheating of device | 3 | 1.2% | 2.5% |
| Unintended ejection | 3 | 1.2% | 0% |
| Circuit failure | 2 | 0.8% | 0.6% |
| Failure to power up | 2 | 0.8% | 5.5% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| No patient involvement | 53 | 21.8% |
| Painpain, site not specified | 5 | 2.1% |
| Shockshock, a collapse of the circulation | 4 | 1.6% |
| Deaththe patient died; cause not stated by this term | 2 | 0.8% |
| Exposure to body fluids | 2 | 0.8% |
| Blood loss | 1 | 0.4% |
| Brain injury | 1 | 0.4% |
| Hemorrhage/blood loss/bleeding | 1 | 0.4% |
| Memory loss/impairment | 1 | 0.4% |
| Radiation exposure, unintended | 1 | 0.4% |
| Tingling | 1 | 0.4% |
| Tissue damage | 1 | 0.4% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Neptune 2 Rover Ultra 120v | Product code JCX | All MAUDE reports |
|---|---|---|---|
| Reports | 243 | 2,154 | 26,136,888 |
| Share of that pool | — | 11.3% | 0% |
| Classified as death, per 1,000 reports | 12 | 25 | 9 |
| Classified as injury | 3.7% | 13% | 36.2% |
| Classified as malfunction | 95.1% | 82.4% | 62.3% |
| Filed by the manufacturer | 100% | 91.7% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code JCX
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Neptune 3 Rover 120v | 188 | 0 | 1.1% |
| Devilbiss | 436 | 9 | 3.9% |
| V A C Therapy System | 364 | 0 | 2.7% |
| Neptune Rover With Smoke Evac And Power Pole | 266 | 0 | 0.4% |
| Gomco | 203 | 20 | 0% |
| V A C Therapy | 225 | 0 | 0.9% |
| Handpiece Electric Dermatome | 1,825 | 174 | 0% |
| Cardinal Health | 589 | 185 | 0.2% |
| Conmed | 900 | 89 | 0.2% |
| Zimmer Air Dermatome | 2,687 | 372 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Neptune 2 Rover Ultra 120v reports
How many FDA reports name Neptune 2 Rover Ultra 120v?
243 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
malfunction (95.1%), injury (3.7%) and death (1.2%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
smoking (22.6%), electrical /electronic property problem (11.9%), sparking (10.3%), suction problem (9.9%) and filtration problem (5.3%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Neptune 2 Rover Ultra 120v was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.